Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infection in patients with clostridium difficile disease and differentiating carrier state from active disease

Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infection in patients with clostridium difficile disease and differentiating carrier state from active disease

US Patent 10295535 · Granted May 21, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fecal lactoferrin as a biomarker for determining disease severity and for treati2019
Fecal lactoferrin as a biomarker for determining disease severity and for treati2019
Fecal lactoferrin as a biomarker for determining disease severity and for treati2019
Nucleic acid extraction using organic solvents to remove inhibitors2019
Nucleic acid extraction using organic solvents to remove inhibitors2019
Nucleic acid extraction using organic solvents to remove inhibitors2016
Nucleic acid extraction using organic solvents to remove inhibitors2016
Outer membrane protein 18 as a diagnostic marker for campylobacter2016
Device and method for detection of analytes2016
Device and method for detection of analytes2016
Cell wall protein CwpV (CD0514) as a diagnostic marker for Clostridium difficile2015
Cysteine protease Cwp84 (CD2787) as a diagnostic marker for Clostridium difficil2014